Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00237510 · ClinicalTrials.gov registry record · NA
Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating
A NA study of Antidepressant Induced Excessive Sweating, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00237510: Completed NA study of Antidepressant Induced Excessive Sweating, sponsored by Thomas Jefferson University.
NCT00237510 is a NA study of Antidepressant Induced Excessive Sweating that has completed, run by Thomas Jefferson University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00237510, a NA study of Antidepressant Induced Excessive Sweating, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be effective in reducing excessive sweating caused by antidepressant treatment, and will have minimal adverse effects.
Conditions Studied
Interventions
- DRUG terazosin
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Department of Psychiatry and Human Behavior - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-05 |
| Phase | NA |
What the finished NCT00237510 record still lists
NCT00237510 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Antidepressant Induced Excessive Sweating appearing as the primary indexed condition, and to 1 intervention - of which terazosin is the first listed.
NCT00237510 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00237510 about?
NCT00237510 is a clinical study titled "Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating". This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be effective in reducing excessive sweating caused by antidepressant treatment, and will have minimal adverse effects.
What is the current status of trial NCT00237510?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2005-05. Estimated completion is 2007-05.
What conditions does trial NCT00237510 study?
This clinical trial studies the following conditions: Antidepressant Induced Excessive Sweating.
What interventions are being tested in trial NCT00237510?
The interventions under investigation include: terazosin (DRUG).
Who is sponsoring clinical trial NCT00237510?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00237510 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00237510's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia